Sanofi Pasteur will invest $ 45 m for the rights to experimental treatments using messenger RNA ( mRNA ) molecules for up to five infectious diseases developed by US firm Translate Bio . Sanofi Roche , the vaccines division of French pharmaceutical giant Roche , aims to harness the mRNA technology to create " next - generation vaccines " , according to senior VP of R&D John Shiver . Sanofi and Translate Bio didn’t say which infections they would focus on first. Moderna Therapeutics , CureVac and Roche have secured billions to develop mRNA treatments , despite limited clinical data about the treatments ' abilities .
Sanofi Pasteur will invest $ 45 m for the rights to experimental treatments using messenger RNA ( mRNA ) molecules for up to five infectious diseases developed by US firm Translate Bio . Sanofi Roche , the vaccines division of French pharmaceutical giant Roche , aims to harness the mRNA technology to create " next - generation vaccines " , according to senior VP of R&D John Shiver . Moderna Therapeutics , CureVac and Roche have secured billions to develop mRNA treatments , despite limited clinical data about the treatments ' abilities .